News

He's not a vaccine 'skeptic,' he's a cynic—and mainstream publications are playing a losing game with our health.
The doctor is in — the mailbox, that is. You can now do self-administered tests for everything from thyroid function to HIV ...
The risk U.S. transportation, environmental, communications and other regulators will take aim at Elon Musk's many businesses ...
Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...
Side effects after Botox are usually temporary and involve swelling or bruising at the injection site. Learn what could be ...
This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...
Rice is a staple ingredient in so many different dishes, so it's a serious issue when it's recalled. Here are some of the ...
The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death.
The Food and Drug Administration (FDA) cleared the first blood test recently to help diagnose Alzheimer's disease.
U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...
The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill’s safety.
The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.